Saturday 17 October 2026
Export ASPI’s income statement to Excel — free account
ASP Isotopes Inc.
ASPI Basic Materials Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024. In the quarter to June 2026, revenue grew 327.6%, EPS grew 73.8%, free cash flow fell 182.9% and total debt rose 162.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.14
0.07
−3.17%
Follow ASPI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
24.74 | 19.86 | 18.62 | 101.62 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(32.71) | (30.11) | (24.88) | (96.17) | |
P/B ratio |
2.78 | 1.79 | 1.69 | 8.82 | |
Price to Tangible BV |
2.85 | 1.83 | 1.73 | 9.62 | |
EV/Sales |
24.89 | 18.58 | 13.36 | 101.84 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(11.32) | (9.55) | (8.43) | (36.04) | |
EV/FCF |
(9.20) | (7.60) | (6.72) | (13.35) | |
Quick Ratio |
3.73 | 4.20 | 11.02 | 5.74 | |
Current Ratio |
3.87 | 4.39 | 12.23 | 6.14 | |
Net Debt/EBITDA |
(0.14) | 1.59 | 5.20 | (0.13) | |
Debt/Assets |
46.06% | 44.01% | 40.53% | 51.28% | |
Debt/Equity |
0.96 | 0.86 | 0.77 | 1.20 | |
Asset Turnover |
0.09 | 0.08 | 0.08 | 0.05 | |
Operating CF/Net income |
0.69 | 2.58 | 0.23 | 0.69 | |
Capex/Depreciation |
(3.30) | (2.01) | 30.55 | (100.60) | |
Interest Coverage |
(19.28) | (14.39) | (96.27) | (102.44) | |
Research and Development Expense of Revenue |
133.20% | 125.91% | 41.11% | 63.37% | |
Selling, General and Administrative Expense of Revenue |
563.17% | 509.35% | 105.26% | 251.39% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.04 | |
Share Based Compensation of Revenue |
88.66% | 105.55% | 35.38% | 91.71% | |
Graham Net Nets |
(0.03) | 0.04 | 0.37 | 0.05 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(21.22%) | (47.06%) | (40.00%) | (14.86%) | |
Free Cash Flow Yield |
(10.93%) | (12.30%) | (10.68%) | (7.51%) | |
Revenue per Share |
0.04 | 0.03 | 0.20 | 0.06 | |
Operating CF per Share |
(0.19) | (0.15) | (0.21) | (0.10) | |
Capex per Share |
(0.03) | (0.05) | 0.33 | (0.37) | |
Free Cash Flow per Share |
(0.22) | (0.20) | 0.12 | (0.47) | |
Cash per Share |
2.11 | 2.42 | 3.94 | 1.29 | |
Shareholders Equity per Share |
2.24 | 2.47 | 3.17 | 1.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.24 | 2.47 | 3.17 | 1.09 | |
Free Cash Flow |
(27.30) | (23.90) | 9.75 | (42.01) | |
Working Capital |
201.89 | 238.37 | 367.22 | 145.72 | |
Capital Expenditures |
(3.97) | (6.14) | 27.60 | (33.15) | |
Net Current Asset Value |
(25.09) | 20.09 | 164.80 | 44.76 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.77 | 1.47 | (1.66) | 6.78 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
17.04 | 1.54 | 16.91 | 24.60 | |
Average Payables |
4.15 | 4.46 | 2.42 | 2.61 | |
Average Inventory |
1.29 | 0.86 | 0.58 | 0.73 | |
Average Assets |
353.98 | 339.27 | 296.18 | 155.01 | |
Average Common Equity |
151.55 | 172.37 | 157.03 | 69.31 |
Columns are period end dates